ROIV — ROIVANT SCIENCES LTD

Ownership history in EntryPoint Capital, LLC  ·  7 quarters on record

This page tracks every 13F SEC filing in which EntryPoint Capital, LLC reported a position in ROIVANT SCIENCES LTD (ROIV). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.27% (2024 Q4)
Avg. % of fund
0.11%
First filed
2023 Q4
Last filed
2025 Q3
Quarters held
7
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 12,382 +963 +8.4% 0.07% $187K $15.13
2025 Q2 REDUCED 11,419 -34,661 -75.2% 0.06% $129K $11.27
2025 Q1 REDUCED 46,080 -7,363 -13.8% 0.21% $465K $10.09
2024 Q4 ADDED 53,443 +40,964 +328.3% 0.27% $632K $11.83
3 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ROIV price (monthly, adj. close)

Other funds also holding ROIV

As of 2025 Q4 — sorted by position size

QVT Financial LP 3Y 7Y 49.1% Patient Square Capital LP 3Y 37.93% Whitefort Capital Management, LP 3Y 11.76% ADAR1 Capital Management, LLC 5.39% BlackBarn Capital Partners LP 4.4% Two Seas Capital LP 3Y 4.38% PENN DAVIS MCFARLAND INC 3Y 7Y 3.86% STEMPOINT CAPITAL LP 3.6% SB INVESTMENT ADVISERS (UK) LTD 3Y 7Y 3.56% PERCEPTIVE ADVISORS LLC 3Y 7Y 3.09%
← Back to EntryPoint Capital, LLC Holdings